Greenleaf Peter 4
4 · Aurinia Pharmaceuticals Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Greenleaf Peter
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2026-01-02+165,384→ 1,954,329 total - Tax Payment
Common Stock
2026-01-02$15.95/sh−113,169$1,805,046→ 1,845,037 total
Footnotes (3)
- [F1]Represents the number of shares earned upon certification of performance for a performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2025 and December 31, 2026.
- [F2]Represents shares withheld to satisfy tax withholding obligations upon the vesting of performance awards.
- [F3]Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,257 common shares were acquired on May 30, 2025 and 1,620 common shares were acquired on November 28, 2025.